J. Olalla Sierra

Efficacy and safety of replacing sitagliptin with canagliflozin in real-world patients with type 2 diabetes uncontrolled with sitagliptin combined with metformin and/or gliclazide: The SITA-CANA Switch Study.

R. Gómez Huelgas, M. D. García de Lucas, M. Suárez Tembra, 2018, Diabetes & metabolism.

Insulin degludec allows for better glycaemic control with a lower risk of hypoglycaemia in patients with chronic kidney disease and type 2 diabetes.

F. Rivas Ruiz, J. Olalla Sierra, María Dolores García de Lucas, 2020, Diabetes research and clinical practice.

Degludec is effective and safe in real‐life treatment for patients with type 2 diabetes mellitus and chronic kidney disease stage 3B

M. D. García de Lucas, J. Olalla Sierra, Beatriz Avilés Bueno, 2018, International journal of clinical practice.

Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy

M. Rubio-Rivas, A. Artero, A. Muiño Míguez, 2021, BMC Infectious Diseases.

Colonic leishmaniasis in a patient with HIV: a case report.

J. de la Torre Lima, J. Olalla Sierra, A. del Arco Jiménez, 2016, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Clinical Results with a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19

G. Criner, J. Janc, Richard A. Miller, 2021, medRxiv.